Here’s what’s on South Africa’s 2026 public health agenda

South Africa is a study in contrasts. And the 2026 public health agenda is no exception.  Breakthrough HIV prevention medicine has arrived alongside US funding cuts. AI could revolutionise TB screening but drug resistance is climbing. New obesity drugs have launched but are unaffordable to nearly everyone. National Health Insurance (NHI) is law but is […]

FDA moves to strike suicide risk warnings from 3 GLP-1s

The FDA is requesting that drugmakers remove suicidal ideation and behavior warnings from the labeling of three GLP-1 receptor agonists — Saxenda (liraglutide), Wegovy (semaglutide) and Zepbound (tirzepatide) — effective Jan. 13, 2026. The FDA’s decision follows a meta-analysis of 91 placebo-controlled trials comprising 107,910 patients, according to a Jan. 13 FDA news release. Of […]

Correction: Improvement effect of a next-generation probiotic L. plantarum-pMG36e-GLP-1 on type 2 diabetes mellitus via the gut–pancreas–liver axis

Food Funct., 2026, Advance ArticleDOI: 10.1039/D6FO90005D, Correction Open Access   This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. Hong Hu, Jie Luo, Ying Liu, Hongyu Li, Rui Jin, Shengjie Li, Jing Wei, Hong Wei, Tingtao ChenTo cite this article before page numbers are assigned, use the DOI form of citation above.The […]

Popular weight-loss drugs shouldn’t carry suicide warnings, FDA says

Federal regulators have told drugmakers Novo Nordisk and Eli Lilly to remove label warnings about potential suicidal thoughts and behaviours from their blockbuster weight-loss medications. The US Food and Drug Administration on Tuesday said a comprehensive review found no increased risk related to suicide among users of the GLP-1 drugs for obesity, including Novo Nordisk’s […]